In 2011, the government formed Korea Drug Development Fund (KDDF) to provide inter-ministerial level support for developing new drug. Ministry of Science and ICT (MSIT), Ministry of Trade, Industry and Energy (MOTIE) and Ministry of Health and Welfare (MOHW) laid down a plan to develop more than ten global-level new drugs by investing on R&D together. The initial plan was to invest 1.6 trillion won for ten years until 2020 (530 billion won by the government, 530 billion won by private investment).

According to the plan, Korea should be able to release ten new drugs by the end of this year. But it seems unrealistic at the moment. Considering Korea’s pharmaceutical and bio industry’s reality, the barr